Nuo Therapeutics Files 8-K for Other Event

TL;DR

Nuo Therapeutics filed an 8-K for an 'Other Event' - details TBD.

AI Summary

Nuo Therapeutics, Inc. filed an 8-K on June 27, 2024, reporting an "Other Event." The filing does not contain specific details about the event, its financial implications, or any associated dates beyond the filing date itself. The company's principal executive offices are located in Houston, Texas.

Why It Matters

This filing indicates a significant event has occurred for Nuo Therapeutics, but the lack of detail leaves investors uncertain about its nature and impact.

Risk Assessment

Risk Level: medium — The filing is an 8-K for an 'Other Event' without providing any specific details, creating uncertainty and potential risk for investors.

Key Players & Entities

• Nuo Therapeutics, Inc. (company) — Registrant
• June 27, 2024 (date) — Filing date and earliest event reported
• 8285 El Rio, Suite 190, Houston, Texas 77054 (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.0001 — 0 shares of Nuo common stock, par value $0.0001 per share (the "Common Stock") at an ex
• $0.56 — "Common Stock") at an exercise price of $0.56 per share for proceeds of $151,200 to N
• $151,200 — rice of $0.56 per share for proceeds of $151,200 to Nuo. Pac Medical also exercised the

Filing Documents

• aurx20240625_8k.htm (8-K) — 20KB
• 0001437749-24-021407.txt ( ) — 141KB
• noticker-20240627.xsd (EX-101.SCH) — 3KB
• noticker-20240627_def.xml (EX-101.DEF) — 10KB
• noticker-20240627_lab.xml (EX-101.LAB) — 14KB
• noticker-20240627_pre.xml (EX-101.PRE) — 11KB
• aurx20240625_8k_htm.xml (XML) — 3KB

01 Other Events

Item 8.01 Other Events. On June 27, 2024, Pacific Medical, Inc, ("Pac Medical") fully exercised a Common Stock Purchase Warrant (the "Warrant') previously issued by Nuo Therapeutics, Inc. ("Nuo") on January 1, 2024 in accordance with a Common Stock and Warrant Purchase Agreement dated August 24, 2022 (the "Agreement"). Pac Medical exercised a portion of the Warrant for the issuance of 270,000 shares of Nuo common stock, par value $0.0001 per share (the "Common Stock") at an exercise price of $0.56 per share for proceeds of $151,200 to Nuo. Pac Medical also exercised the remaining portion of the Warrant representing 230,000 shares of Common Stock on a cashless basis for the issuance of 86,889 shares of Common Stock. As a result, an aggregate of 356,889 shares of Common Stock were issued to Pac Medical. The Warrant and the Agreement were described in and included as exhibits to a Current Report on Form 8-K filed by Nuo on August 30, 2022 and the most recent Annual Report on Form 10-K filed by Nuo on April 19, 2024. As a result of the Warrant exercise, the number of shares of Common Stock outstanding is 45,466,238.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Nuo Therapeutics, Inc. By: /s/ David E. Jorden David E. Jorden Chief Executive and Chief Financial Officer Date: June 27, 2024

View Full Filing

View this 8-K filing on SEC EDGAR